Sanofi Forces Genzyme's Hand With Hostile Bid

With no white knight in Genzyme's corner, Sanofi commences a tender offer for Genzyme at $69-per-share.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet